Salo et al developed a staging system for malignant fibrous histiocytomas (MFH) involving an extremity. This can help identify a patient who may require more aggressive management. The authors are from Loma Linda University and Memorial Sloan-Kettering Cancer Center.
Parameters:
(1) histologic grade
(2) diameter in centimeters
(3) location
Grade |
Diameter |
Location |
Stage |
---|---|---|---|
low |
<= 5 cm |
superficial |
Stage I |
low |
<= 5 cm |
deep |
Stage I |
low |
> 5 cm |
superficial |
Stage I |
low |
> 5 cm |
deep |
Stage II |
high |
<= 5 cm |
superficial |
Stage II |
high |
<= 5 cm |
deep |
Stage II |
high |
> 5 cm |
superficial |
Stage II |
high |
5.01 - 10 cm |
deep |
Stage IIIa |
high |
> 10 cm |
deep |
Stage IIIb |
where:
• A superficial location is superficial to the muscular fascia. A deep location involved the muscular fascia or was deep to it.
• A low grade tumor is AJCC histologic grade G1 or G2; a high grade tumor is AJCC histologic grade G3 or G4.
Stage |
Mean Probability of 10 Year Disease Specific Survival |
---|---|
I |
100% |
II |
79% |
IIIa |
48% |
IIIb |
31% |
Purpose: To evaluate a patient with a malignant fibrous histiocytoma arising in an extremity using the staging system of Salo et al.
Specialty: Hematology Oncology, Surgery, general, Surgery, orthopedic
Objective: severity, prognosis, stage
ICD-10: C49, M10,